Showing results (351-360 of 510) with videos related to

Sort By:
Pageof 51
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
The New England Journal of Medicine|August 18, 2021
Atogepant for the Preventive Treatment of MigraineJessica Ailani, Richard B Lipton, Peter J Goadsby, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Neurobiology of Disease|December 3, 2014
Evidence for orexinergic mechanisms in migraineJan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
The Journal of Headache and Pain|December 2, 2022
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER studyPiero Barbanti, Peter J Goadsby, Giorgio Lambru, et al.
European Journal of Neurology|December 30, 2022
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failuresPeter J Goadsby, Piero Barbanti, Giorgio Lambru, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Headache|October 27, 2025
Evaluating associations of migraine-related vertigoNazia Karsan, Nicolas Vandenbussche, Robyn Jenia-Wilcha, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Pageof 51